Table 1.
The impact of obesity on T cell subsets in the peripheral blood and bone marrow of OA patients.
Normal weight (BMI 18.5–24.9) | Obese (BMI ≥ 30.0) | |||
---|---|---|---|---|
PB | BM | PB | BM | |
CD4:CD8 ratio | 2.7 ± 0.8 | 0.7 ± 0.1 | 2.9 ± 0.6 | 1.4 ± 0.3 |
CD4 + T cells | ||||
% TN | 45.5 ± 6.6 | 25.8 ± 5.8 | 43.3 ± 3.8 | 31.4 ± 4.3 |
% TCM | 34.3 ± 3.6 | 31 ± 5 | 40.9 ± 3.2 | 33.7 ± 2.7 |
% TEM | 14.1 ± 4.3 | 38.9 ± 4.8 | 13.9 ± 1.8 | 32.3 ± 3.4 |
% TEMRA | 5.4 ± 1.2 | 4.3 ± 1 | 3.3 ± 1.2 | 2.7 ± 0.4 |
% CD28− | 1.5 ± 0.6 | 1.7 ± 0.4 | 1.1 ± 0.4 | 1.3 ± 0.4 |
% CD69+ | 0.2 ± 0.1 | 15.3 ± 1.9 | 0.4 ± 0.2 | 15.2 ± 2.5 |
% Treg | 3 ± 0.4 | 3.3 ± 0.7 | 3.5 ± 0.9 | 3 ± 0.4 |
% IFN-γ+ | 19.2 ± 3.4 | 31.7 ± 6 | 10.1 ± 1.9 | 21.2 ± 6.2 |
% IL-4+ | 3.7 ± 1.1 | 3.4 ± 0.9 | 2.4 ± 0.7 | 1.6 ± 0.7 |
% IL-2+ | 59.7 ± 5.1 | 47.4 ± 8.7 | 55.1 ± 5.7 | 32.5 ± 8.3 |
% IL-10+ | 0.38 ± 0.06 | 1.6 ± 0.6 | 0.29 ± 0.05 | 1.7 ± 0.2 |
% IL-17A+ | 0.34 ± 0.11 | 0.67 ± 0.32 | 0.77 ± 0.12 | 1.14 ± 0.16 |
% IL-17A+ IFN-γ+ | 0.01 ± 0.004 | 0.14 ± 0.06 | 0.09 ± 0.05 | 0.39 ± 0.08 |
% polyfunctional | 10.9 ± 1.3 | 19.8 ± 4.2 | 6.3 ± 1.3 | 10.8 ± 6.6 |
CD8 + T cells | ||||
% TN | 14.8 ± 5.5 | 6.3 ± 0.9 | 12.3 ± 2.4 | 8.6 ± 1.3 |
% TCM | 15.3 ± 2.6 | 12.3 ± 3.9 | 19.9 ± 3.9 | 14 ± 1.7 |
% TEM | 37.2 ± 6.1 | 51.6 ± 2.4 | 38.2 ± 7.2 | 50.5 ± 3.9 |
% TEMRA | 32.7 ± 4.5 | 29.7 ± 5 | 29.6 ± 4.6 | 26.9 ± 3.4 |
% CD28− | 46.7 ± 9.8 | 32.5 ± 4.1 | 43.2 ± 10.5 | 32.3 ± 6.1 |
% CD28− CD57+ | 28.1 ± 10.8 | 6.5 ± 3.1 | 33.5 ± 8.9 | 11.5 ± 4.9 |
% CD69+ | 1.1 ± 0.3 | 44.4 ± 5.8 | 1.5 ± 0.3 | 52.1 ± 5.6 |
% IFN-γ+ | 47.8 ± 10.4 | 54 ± 9.6 | 49.7 ± 9.5 | 64.2 ± 11.3 |
% IL-2+ | 22.1 ± 6.6 | 21.4 ± 7.1 | 19.6 ± 5.5 | 22.1 ± 7.6 |
% polyfunctional | 13.9 ± 2.8 | 19.3 ± 4.3 | 11 ± 3.5 | 22.9 ± 1.6 |
Data are expressed as mean ± SEM. Treg cells were defined as CD25hi CD127dim cells. Polyfunctionality was defined as cells that simultaneously produced IFN-γ, TNF-α and IL-2. PB = peripheral blood; BM = bone marrow.